SCHEMBL1719121

SCHEMBL1719121

CCCN(CCC)CCc1ccc(CS(=O)(=O)c2ccc(C(C)C)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 4/20 0.45
DRD2 P14416 3/20 0.45
KCNH2 Q12809 2/20 0.45
RORC P51449 1/20 0.41
CNR2 P34972 3/20 0.40
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
DRD1 P21728 1/20 0.39
DRD4 P21917 1/20 0.39
DRD5 P21918 1/20 0.39
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
HIF1A Q16665 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4924167 0.99 DRD3 (0.44) DRD3DRD2KCNH2RORCCNR2
SCHEMBL1719317 0.83 DRD3 (0.42) DRD3DRD2KCNH2CNR2CA12
Hydrochloric Acid SCHEMBL4918974 0.82 DRD3 (0.42) DRD3DRD2KCNH2CNR2CA12
SCHEMBL2472844 0.81 CNR2 (0.47) CNR2TSHRMLNRCNR1POLB
SCHEMBL2466084 0.81 FFAR1 (0.51) DRD3DRD2KCNH2POLB
Hydrochloric Acid SCHEMBL4910525 0.80 CNR2 (0.47) CNR2TSHRMLNRCNR1POLB
Hydrochloric Acid SCHEMBL4914708 0.80 FFAR1 (0.50) DRD3DRD2KCNH2POLB
SCHEMBL1718526 0.79 CA12 (0.50) DRD3DRD2KCNH2CNR2CYP2D6
SCHEMBL1718790 0.78 DRD3 (0.45) DRD3DRD2KCNH2CA12CA1
Hydrochloric Acid SCHEMBL4918778 0.77 DRD3 (0.44) DRD3DRD2KCNH2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1809597-B1 AMINOETHYLAROMATIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO KG (DE) 2012-01-11 EP disclosed
EP-2371814-A1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor Abbott GmbH & Co. KG (DE) 2011-10-05 EP disclosed
EP-1809597-A1 AMINOETHYLAROMATIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR Abbott GmbH & Co. KG (DE) 2007-07-25 EP disclosed
WO-2006040179-A1 AMINOETHYLAROMATIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO. KG (DE) 2006-04-20 WO disclosed